Edward Walker, Senior Scientist at the New Zealand Institute for Bioeconomy Science
SGLT-2 inhibitor and GLP-1 receptor agonist treatment for patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: is their combination the optimal treatment option
At Flawless MedSpa in Las Vegas, NV, Melanie Speed, APRN, NP-C, CANS , provides customized Ozempic plans tailored to individual health and wellness goals
Liver and Detox Support Aids in clearing excess lipids from the liver (beneficial for NAFLD) Enhances methylation-based detox of xenobiotics and estrogen metabolites Improves glutathione production and antioxidant capacity 3
Employers seek solutions While these drugs represent a small fraction of prescriptions, their financial impact is outsized
Additionally, long-term demand is indirectly reinforced by initiatives that support domestic pharmaceutical manufacturing, preventive healthcare programs, and obesity awareness campaigns